Medical Advisory from consultants in Diabetes care

1. In your practice, what is your preferred therapy in a newly detected diabetic patient with HbA1c ≥7.5%
A. Metformin
B. SU + Metformin
C. DPP4-i + Metformin
D. SGLT2-i + Metformin

2. In your practice, what is your preferred therapy in a newly detected diabetic patient with HbA1c >9%
A. Intensified SU + Metformin therapy
B. Initiation of DPP4-i + Metformin therapy
C. Pioglitazone triple therapy
D. Insulin

3. How common is Microalbuminuria in your T2DM patients?

A. 1 in 10
B. 2 in 10
C. 3 in 10
D. Others: ____________________________ Please specify

4. Do you recommend dip stick screening for Microalbuminuria?

A. Yes
B. No

5. Your preferred gliptin in patient having impaired renal function

A. Sitagliptin
B. Vildagliptin
C. Teneligliptin
D. None of the above

6. Considering the Covid-19 pandemic can you rank the OAD in the order of preference?
 Glimepiride + Metformin
 Sitagliptin + Metformin
 Teneligliptin + Metformin
 Linagliptin + Metformin
 Glimepiride + Metformin + Pioglitazone
 Dapagliflozin + Metformin
 Empagliflozin + Metformin
 Metformin
7. In T2DM patient diagnosed with NAFLD which is your Preferred OAD?

A) Glimepiride
B) Metformin
C) Pioglitazone
D) Insulin
E) Others : __________________

8. In T2DM patients with CVD which is your preferred therapy?

A. Insulin
B. Pioglitazone Triple therapy
C. DPP 4 + Metformin Therapy
D. SGLT2 Inhibitors
E. SU + metformin therapy

9. Does tablet Shape and size matters for patient compliance

A. Yes
B. No

10. Does Sustained Release Metformin in DPP4 + metformin combinations improve patient adherence and
compliance?
A. Yes
B. No

11. Are you using any of the digital platforms for teleconsultation with your patients?
A. Yes
B. No

12. Can you share with us what percentage of your patients are comfortable with teleconsultation?
 10%
 20%
 30%
 40%
 50%
 100%

Name of the doctor:

Signature and rubber stamp:
Date: